Home Cart 0 Sign in  

[ CAS No. 84946-20-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 84946-20-3
Chemical Structure| 84946-20-3
Structure of 84946-20-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 84946-20-3 ]

Related Doc. of [ 84946-20-3 ]

Alternatived Products of [ 84946-20-3 ]

Product Details of [ 84946-20-3 ]

CAS No. :84946-20-3 MDL No. :MFCD00800240
Formula : C14H10ClFN2 Boiling Point : -
Linear Structure Formula :- InChI Key :PGXALMVNIRPELS-UHFFFAOYSA-N
M.W : 260.69 Pubchem ID :3020241
Synonyms :

Calculated chemistry of [ 84946-20-3 ]

Physicochemical Properties

Num. heavy atoms : 18
Num. arom. heavy atoms : 15
Fraction Csp3 : 0.07
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 70.45
TPSA : 17.82 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.98 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.67
Log Po/w (XLOGP3) : 4.1
Log Po/w (WLOGP) : 4.3
Log Po/w (MLOGP) : 3.72
Log Po/w (SILICOS-IT) : 3.88
Consensus Log Po/w : 3.74

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.52
Solubility : 0.0078 mg/ml ; 0.0000299 mol/l
Class : Moderately soluble
Log S (Ali) : -4.18
Solubility : 0.0172 mg/ml ; 0.0000661 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -5.91
Solubility : 0.000324 mg/ml ; 0.00000124 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.78

Safety of [ 84946-20-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 84946-20-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 84946-20-3 ]
  • Downstream synthetic route of [ 84946-20-3 ]

[ 84946-20-3 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 4857-06-1 ]
  • [ 459-46-1 ]
  • [ 84946-20-3 ]
YieldReaction ConditionsOperation in experiment
91.1%
Stage #1: With potassium hydroxide In acetonitrile at 80℃; for 0.5 h;
Stage #2: at 80℃; for 5 h;
To a solution of 2-chlorobenzomethylene (5 g, 32.7 mmol) was added 30 ml of acetonitrile and potassium hydroxide (2.62 g, 46.6 mmol) Heated to 80 ° C, stirred for 30min, the solution clarified; after cooling to room temperature, adding bromine bromide (9.29g, 49.1 mmol) 80 ° C reflux 5h, the reaction solution was white turbid; the reaction solution with dichloromethane extraction three times (100mLX3), distilled water The organic layers were combined, dried over anhydrous magnesium sulfate, suction filtered and concentrated to give a white solid which was recrystallized from acetone / petroleum ether and cooled And filtered, dried to give a white solid in a yield of 91.1percent.
Reference: [1] ACS Medicinal Chemistry Letters, 2016, vol. 7, # 3, p. 245 - 249
[2] Patent: CN104910894, 2017, B, . Location in patent: Paragraph 0032; 0034; 0036; 0037; 0055
[3] Journal of Medicinal Chemistry, 2007, vol. 50, # 25, p. 6291 - 6294
[4] Heterocycles, 1999, vol. 51, # 11, p. 2561 - 2573
[5] Patent: US5922737, 1999, A,
[6] Patent: US6211199, 2001, B1,
[7] European Journal of Medicinal Chemistry, 2014, vol. 84, p. 395 - 403
[8] European Journal of Medicinal Chemistry, 2014, vol. 84, # C, p. 395 - 403
  • 2
  • [ 100460-87-5 ]
  • [ 84946-20-3 ]
Reference: [1] Synthetic Communications, 1996, vol. 26, # 17, p. 3323 - 3329
[2] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 18, p. 5443 - 5448
[3] European Journal of Medicinal Chemistry, 2014, vol. 84, p. 395 - 403
[4] European Journal of Medicinal Chemistry, 2014, vol. 84, # C, p. 395 - 403
  • 3
  • [ 4857-06-1 ]
  • [ 352-11-4 ]
  • [ 84946-20-3 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2016, vol. 53, # 6, p. 1871 - 1877
[2] Synthetic Communications, 1996, vol. 26, # 17, p. 3323 - 3329
[3] Patent: US5461059, 1995, A,
[4] Patent: US4695575, 1987, A,
  • 4
  • [ 4857-06-1 ]
  • [ 7191-70-0 ]
  • [ 84946-20-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 24, p. 6332 - 6344
  • 5
  • [ 459-46-1 ]
  • [ 84946-20-3 ]
Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 84, p. 395 - 403
[2] European Journal of Medicinal Chemistry, 2014, vol. 84, # C, p. 395 - 403
[3] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 24, p. 6332 - 6344
  • 6
  • [ 7191-70-0 ]
  • [ 84946-20-3 ]
Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 84, p. 395 - 403
[2] European Journal of Medicinal Chemistry, 2014, vol. 84, # C, p. 395 - 403
  • 7
  • [ 88-74-4 ]
  • [ 84946-20-3 ]
Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 84, p. 395 - 403
[2] European Journal of Medicinal Chemistry, 2014, vol. 84, # C, p. 395 - 403
  • 8
  • [ 100460-79-5 ]
  • [ 84946-20-3 ]
Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 84, p. 395 - 403
[2] European Journal of Medicinal Chemistry, 2014, vol. 84, # C, p. 395 - 403
  • 9
  • [ 95-54-5 ]
  • [ 84946-20-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 24, p. 6332 - 6344
  • 10
  • [ 615-16-7 ]
  • [ 84946-20-3 ]
Reference: [1] Synthetic Communications, 1996, vol. 26, # 17, p. 3323 - 3329
[2] Synthetic Communications, 1996, vol. 26, # 17, p. 3323 - 3329
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 84946-20-3 ]

Fluorinated Building Blocks

Chemical Structure| 108662-49-3

[ 108662-49-3 ]

2-Chloro-6-fluoro-1H-benzo[d]imidazole

Similarity: 0.82

Chemical Structure| 256519-11-6

[ 256519-11-6 ]

2-Chloro-7-fluoro-1H-benzo[d]imidazole

Similarity: 0.78

Chemical Structure| 1977-72-6

[ 1977-72-6 ]

5-Fluoro-1H-benzo[d]imidazole

Similarity: 0.71

Chemical Structure| 769158-12-5

[ 769158-12-5 ]

2-Chloro-6-fluoroquinazolin-4(3H)-one

Similarity: 0.66

Chemical Structure| 86604-86-6

[ 86604-86-6 ]

2-Chloro-6-(trifluoromethyl)benzimidazole

Similarity: 0.64

Aryls

Chemical Structure| 2622-63-1

[ 2622-63-1 ]

1-Methyl-2-phenyl-1H-benzo[d]imidazole

Similarity: 0.64

Chemical Structure| 85979-59-5

[ 85979-59-5 ]

2-Chloro-4-(4-fluoro-phenyl)-pyrimidine

Similarity: 0.63

Chemical Structure| 2622-60-8

[ 2622-60-8 ]

1-Phenyl-1H-benzoimidazole

Similarity: 0.62

Chemical Structure| 621-72-7

[ 621-72-7 ]

2-Benzyl-1H-benzo[d]imidazole

Similarity: 0.60

Chemical Structure| 2963-77-1

[ 2963-77-1 ]

4-(1H-Benzo[d]imidazol-2-yl)aniline

Similarity: 0.60

Chlorides

Chemical Structure| 108662-49-3

[ 108662-49-3 ]

2-Chloro-6-fluoro-1H-benzo[d]imidazole

Similarity: 0.82

Chemical Structure| 256519-11-6

[ 256519-11-6 ]

2-Chloro-7-fluoro-1H-benzo[d]imidazole

Similarity: 0.78

Chemical Structure| 15965-57-8

[ 15965-57-8 ]

2-Chloro-7-methyl-1H-benzo[d]imidazole

Similarity: 0.73

Chemical Structure| 4857-06-1

[ 4857-06-1 ]

2-Chloro-1H-benzo[d]imidazole

Similarity: 0.67

Chemical Structure| 1609452-31-4

[ 1609452-31-4 ]

7,8-Dibromo-2-chloro-9-methyl-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline

Similarity: 0.66

Related Parent Nucleus of
[ 84946-20-3 ]

Benzimidazoles

Chemical Structure| 108662-49-3

[ 108662-49-3 ]

2-Chloro-6-fluoro-1H-benzo[d]imidazole

Similarity: 0.82

Chemical Structure| 256519-11-6

[ 256519-11-6 ]

2-Chloro-7-fluoro-1H-benzo[d]imidazole

Similarity: 0.78

Chemical Structure| 15965-57-8

[ 15965-57-8 ]

2-Chloro-7-methyl-1H-benzo[d]imidazole

Similarity: 0.73

Chemical Structure| 1977-72-6

[ 1977-72-6 ]

5-Fluoro-1H-benzo[d]imidazole

Similarity: 0.71

Chemical Structure| 4857-06-1

[ 4857-06-1 ]

2-Chloro-1H-benzo[d]imidazole

Similarity: 0.67